Announcement on Capital Reduction of Holding Subsidiary
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Jiangsu Nanfang Medical Co., Ltd. announced a capital reduction for its holding subsidiary, Anhui Huize New Materials Technology Co., Ltd. The reduction will decrease the registered capital from a certain amount to a lower amount, with the company and other shareholders proportionally reducing their contributions. This decision was made during a board meeting and does not require shareholder approval as it falls within the board's authority. The company assures that this reduction will not affect its consolidated financial statements or the interests of minority shareholders.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jiangsu Nanfang Medical Co., Ltd. on 6ix
Earlier from Jiangsu Nanfang Medical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
- Announcement on Application for Comprehensive Credit Line from Banks and Other Financial Institutions and Provision of Guarantee in 2026
- Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
- Announcement on Resignation of the Company's Director and Chief Financial Officer and Appointment of the General Manager to Perform the Duties of the Chief Financial Officer
Later from Jiangsu Nanfang Medical
- Announcement on Pledge Release and Re-pledge of Partial Shares Held by Controlling Shareholder
- Announcement on Progress in Wholly-owned Subsidiary Providing Guarantee for the Company
- Indicative Announcement on Negotiated Transfer of Partial Shares by Controlling Shareholder and Equity Changes
- Semi-annual Performance Forecast for 2026
- Announcement on Pledge of Certain Shares Held by Persons Acting in Concert with the Controlling Shareholder
Follow Jiangsu Nanfang Medical into a list and get an email when it puts out news.
Follow Jiangsu Nanfang Medical